| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2006-08-13 01:15:00 UTC |
|---|
| Update Date | 2021-09-14 15:48:20 UTC |
|---|
| HMDB ID | HMDB0003601 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | (S)-Reticuline |
|---|
| Description | (S)-Reticuline is an endogenous precursor of morphine (PMID: 15383669 ). (S)-Reticuline is a key intermediate in the synthesis of morphine, the major active metabolite of the opium poppy. "Endogenous morphine" has been long isolated and authenticated by mass spectrometry in trace amounts from animal- and human-specific tissue or fluids (PMID: 15874902 ). Human neuroblastoma cells (SH-SY5Y) were shown capable of synthesizing morphine as well. (S)-Reticuline undergoes a change of configuration at C-1 during its transformation into salutaridinol and thebaine. From thebaine, there is a bifurcate pathway leading to morphine proceeding via codeine or oripavine, in both plants and mammals (PMID 15937106 ). |
|---|
| Structure | COC1=C(O)C=C(C[C@@H]2N(C)CCC3=CC(OC)=C(O)C=C23)C=C1 InChI=1S/C19H23NO4/c1-20-7-6-13-10-19(24-3)17(22)11-14(13)15(20)8-12-4-5-18(23-2)16(21)9-12/h4-5,9-11,15,21-22H,6-8H2,1-3H3/t15-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (+)-Reticuline | ChEBI | | (S)-(+)-Reticuline | ChEBI | | L-(+)-Reticuline | ChEBI | | Reticline | ChEBI | | Reticulin | HMDB | | Reticuline | HMDB | | S-(+)-Reticuline | HMDB | | (1S)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol | HMDB | | (S)-Reticulene | HMDB | | (S)-Reticuline | HMDB |
|
|---|
| Chemical Formula | C19H23NO4 |
|---|
| Average Molecular Weight | 329.3902 |
|---|
| Monoisotopic Molecular Weight | 329.162708229 |
|---|
| IUPAC Name | (1S)-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol |
|---|
| Traditional Name | (+,-)-reticuline |
|---|
| CAS Registry Number | 485-19-8 |
|---|
| SMILES | COC1=C(O)C=C(C[C@@H]2N(C)CCC3=CC(OC)=C(O)C=C23)C=C1 |
|---|
| InChI Identifier | InChI=1S/C19H23NO4/c1-20-7-6-13-10-19(24-3)17(22)11-14(13)15(20)8-12-4-5-18(23-2)16(21)9-12/h4-5,9-11,15,21-22H,6-8H2,1-3H3/t15-/m0/s1 |
|---|
| InChI Key | BHLYRWXGMIUIHG-HNNXBMFYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzylisoquinolines. These are organic compounds containing an isoquinoline to which a benzyl group is attached. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isoquinolines and derivatives |
|---|
| Sub Class | Benzylisoquinolines |
|---|
| Direct Parent | Benzylisoquinolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzylisoquinoline
- Methoxyphenol
- Tetrahydroisoquinoline
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- Alkyl aryl ether
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Phenol
- Monocyclic benzene moiety
- Benzenoid
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Azacycle
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | Not Available |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.38 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.5386 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.05 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 34.7 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1043.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 194.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 149.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 158.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 75.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 420.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 354.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 500.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 764.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 314.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1038.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 206.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 289.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 473.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 394.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 12.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| (S)-Reticuline,1TMS,isomer #1 | COC1=CC2=C(C=C1O)[C@H](CC1=CC=C(OC)C(O[Si](C)(C)C)=C1)N(C)CC2 | 2743.3 | Semi standard non polar | 33892256 | | (S)-Reticuline,1TMS,isomer #2 | COC1=CC=C(C[C@H]2C3=CC(O[Si](C)(C)C)=C(OC)C=C3CCN2C)C=C1O | 2735.7 | Semi standard non polar | 33892256 | | (S)-Reticuline,2TMS,isomer #1 | COC1=CC=C(C[C@H]2C3=CC(O[Si](C)(C)C)=C(OC)C=C3CCN2C)C=C1O[Si](C)(C)C | 2720.9 | Semi standard non polar | 33892256 | | (S)-Reticuline,1TBDMS,isomer #1 | COC1=CC2=C(C=C1O)[C@H](CC1=CC=C(OC)C(O[Si](C)(C)C(C)(C)C)=C1)N(C)CC2 | 2980.3 | Semi standard non polar | 33892256 | | (S)-Reticuline,1TBDMS,isomer #2 | COC1=CC=C(C[C@H]2C3=CC(O[Si](C)(C)C(C)(C)C)=C(OC)C=C3CCN2C)C=C1O | 2973.1 | Semi standard non polar | 33892256 | | (S)-Reticuline,2TBDMS,isomer #1 | COC1=CC=C(C[C@H]2C3=CC(O[Si](C)(C)C(C)(C)C)=C(OC)C=C3CCN2C)C=C1O[Si](C)(C)C(C)(C)C | 3152.7 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - (S)-Reticuline GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-0900000000-480c5be967ad0cdfe3a1 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (S)-Reticuline GC-MS (2 TMS) - 70eV, Positive | splash10-08fr-1290200000-e4ec7775ca969ba4d67d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - (S)-Reticuline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 10V, Positive-QTOF | splash10-001i-0009000000-efd80efd0b57900a92da | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 20V, Positive-QTOF | splash10-0f7p-0934000000-7c33a1bd7de9666c1d8f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 40V, Positive-QTOF | splash10-0fk9-1920000000-12f84a978a4144057a4d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 10V, Negative-QTOF | splash10-004i-0009000000-4d4cbd0c33fe742e473f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 20V, Negative-QTOF | splash10-004i-0029000000-2bde34377f488f00c9fb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 40V, Negative-QTOF | splash10-06zc-0191000000-c4dcb047f808604a6e88 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 10V, Positive-QTOF | splash10-001i-0019000000-e3b1ce90ac36f283f151 | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 20V, Positive-QTOF | splash10-000x-0932000000-ab4976b621ab97468da0 | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 40V, Positive-QTOF | splash10-0imj-0921000000-bc3bc4c37bf770f60e62 | 2021-09-21 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 10V, Negative-QTOF | splash10-004i-0009000000-48c9693a0346ebfa2d97 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 20V, Negative-QTOF | splash10-004i-0169000000-ecf1a66856c22584f73c | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-Reticuline 40V, Negative-QTOF | splash10-00wa-0492000000-ef65d9cac11130e20cb8 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Al-Amri AM, Smith RM, El-Haj BM, Juma'a MH: The GC-MS detection and characterization of reticuline as a marker of opium use. Forensic Sci Int. 2004 Mar 10;140(2-3):175-83. [PubMed:15036439 ]
- Al-Amri AM, Smith RM, El-Haj BM, Juma'a MH: The GC-MS detection and characterization of reticuline as a marker of opium use. Forensic Sci Int. 2004 May 28;142(1):61-9. [PubMed:15272474 ]
- Poeaknapo C, Schmidt J, Brandsch M, Drager B, Zenk MH: Endogenous formation of morphine in human cells. Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14091-6. Epub 2004 Sep 21. [PubMed:15383669 ]
- Poeaknapo C: Mammalian morphine: de novo formation of morphine in human cells. Med Sci Monit. 2005 May;11(5):MS6-17. Epub 2005 Apr 28. [PubMed:15874902 ]
- Boettcher C, Fellermeier M, Boettcher C, Drager B, Zenk MH: How human neuroblastoma cells make morphine. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8495-500. Epub 2005 Jun 3. [PubMed:15937106 ]
|
|---|